CompaniesDemetrix

Demetrix

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

260

By Phase

PHASE3: 3

By Status

WITHDRAWN: 2UNKNOWN: 1

Clinical Trials Pipeline3 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2019

2020

2021

Today

Hover over trial bars to see details

Recent Trials

NCT04361032Collaborator

Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia

260 participants

Started: Sep 4, 2020 · Completed: Oct 4, 2020

NCT04528927Collaborator

Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia

PHASE3Withdrawn

Started: May 15, 2020 · Completed: Jul 15, 2020

NCT04349228Collaborator

Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals

PHASE3Withdrawn

Started: Apr 28, 2020 · Completed: Jul 15, 2020

Funding History (6)

D/A

Feb 10, 2021

D/A

Jul 10, 2020

D

Jul 11, 2019

D/A

Jan 7, 2019

D/A

Jan 8, 2018

D

Sep 6, 2017